中华普通外科杂志
中華普通外科雜誌
중화보통외과잡지
CHINESE JOURNAL OF GENERAL SURGERY
2011年
9期
713-716
,共4页
赵永亮%余佩武%钱锋%石彦%唐波%郝迎学%罗华星%兰远志
趙永亮%餘珮武%錢鋒%石彥%唐波%郝迎學%囉華星%蘭遠誌
조영량%여패무%전봉%석언%당파%학영학%라화성%란원지
胃肿瘤%腹腔镜%胃切除术%淋巴结切除术
胃腫瘤%腹腔鏡%胃切除術%淋巴結切除術
위종류%복강경%위절제술%림파결절제술
Stomach neoplasms%Laparoscope%Gastrectomy%Lymph node excision
目的 探讨进展期胃癌腹腔镜根治术的安全性和可行性,并评价其远期临床疗效。方法 对2004年1月至2009年6月远端进展期胃癌行腹腔镜辅助胃癌根治术346例患者的临床及随访资料和同期在我院行传统开腹胃癌手术的313例进行回顾性分析,比较两组的手术安全性、术后并发症、生存率以及癌症复发转移情况。结果 腹腔镜组手术平均用时与开腹组相比差异无统计学意义[(211±56) min比(204±41)min,P>0.05]。腹腔镜组术中出血量、切口长度显著低于开腹手术组。腹腔镜组肿瘤近、远端切缘长度分别为(6.3±2.0) cm、(5.7±1.7)cm,开腹组分别为(6.3±2.1) cm、(5.6±1.6) cm,两组相比差异均无统计学意义。腹腔镜组淋巴结清扫数量为(33±13)枚,开腹组为(33±16)枚,两组相比差异无统计学意义。腹腔镜组术后并发症的发生率显著低于开腹组(6.7%比13.1%,P<0.01)。随访时间6~72个月,平均37个月,腹腔镜组1、3、5年生存率分别为87.2%、57.2%和50.3%,开腹组分别为87.1%、54.1%和49.2%,两组相比差异均无统计学意义。两组癌症复发转移率相比差异无统计学意义。结论 腹腔镜辅助的进展期胃癌根治术与开腹组在生存率及术后复发方面无显著差异,且具有创伤小、术后恢复快、并发症少等优点。
目的 探討進展期胃癌腹腔鏡根治術的安全性和可行性,併評價其遠期臨床療效。方法 對2004年1月至2009年6月遠耑進展期胃癌行腹腔鏡輔助胃癌根治術346例患者的臨床及隨訪資料和同期在我院行傳統開腹胃癌手術的313例進行迴顧性分析,比較兩組的手術安全性、術後併髮癥、生存率以及癌癥複髮轉移情況。結果 腹腔鏡組手術平均用時與開腹組相比差異無統計學意義[(211±56) min比(204±41)min,P>0.05]。腹腔鏡組術中齣血量、切口長度顯著低于開腹手術組。腹腔鏡組腫瘤近、遠耑切緣長度分彆為(6.3±2.0) cm、(5.7±1.7)cm,開腹組分彆為(6.3±2.1) cm、(5.6±1.6) cm,兩組相比差異均無統計學意義。腹腔鏡組淋巴結清掃數量為(33±13)枚,開腹組為(33±16)枚,兩組相比差異無統計學意義。腹腔鏡組術後併髮癥的髮生率顯著低于開腹組(6.7%比13.1%,P<0.01)。隨訪時間6~72箇月,平均37箇月,腹腔鏡組1、3、5年生存率分彆為87.2%、57.2%和50.3%,開腹組分彆為87.1%、54.1%和49.2%,兩組相比差異均無統計學意義。兩組癌癥複髮轉移率相比差異無統計學意義。結論 腹腔鏡輔助的進展期胃癌根治術與開腹組在生存率及術後複髮方麵無顯著差異,且具有創傷小、術後恢複快、併髮癥少等優點。
목적 탐토진전기위암복강경근치술적안전성화가행성,병평개기원기림상료효。방법 대2004년1월지2009년6월원단진전기위암행복강경보조위암근치술346례환자적림상급수방자료화동기재아원행전통개복위암수술적313례진행회고성분석,비교량조적수술안전성、술후병발증、생존솔이급암증복발전이정황。결과 복강경조수술평균용시여개복조상비차이무통계학의의[(211±56) min비(204±41)min,P>0.05]。복강경조술중출혈량、절구장도현저저우개복수술조。복강경조종류근、원단절연장도분별위(6.3±2.0) cm、(5.7±1.7)cm,개복조분별위(6.3±2.1) cm、(5.6±1.6) cm,량조상비차이균무통계학의의。복강경조림파결청소수량위(33±13)매,개복조위(33±16)매,량조상비차이무통계학의의。복강경조술후병발증적발생솔현저저우개복조(6.7%비13.1%,P<0.01)。수방시간6~72개월,평균37개월,복강경조1、3、5년생존솔분별위87.2%、57.2%화50.3%,개복조분별위87.1%、54.1%화49.2%,량조상비차이균무통계학의의。량조암증복발전이솔상비차이무통계학의의。결론 복강경보조적진전기위암근치술여개복조재생존솔급술후복발방면무현저차이,차구유창상소、술후회복쾌、병발증소등우점。
Objective To evaluate the feasibility, safety and the long-term outcomes of laparoscopy-assisted distal gastrectomy (LADG) for advanced gastric cancer (AGC). Methods We retrospectively analyzed the clinical and follow-up data of 346 cases after LADG from January 2004 to June 2009, compared with 313 cases after conventional open distal gastrectomy (ODG) for advanced gastric cancer at the same period at our hospital. The surgical safety, postoperative complications, survival rate, and the recurrence and metastasis of cancer were compared. Results There was no significant difference at the average time of LADG and ODG procedures (211 ± 56) min vs. (204 ±41 ) min, but blood loss during operation and length of incision in LADG group were significantly less than in the ODG group. The proximal and distal length were, respectively, (6. 3 ± 2. 0) cm and (5. 7 ± 1.7 ) cm in LADG group and (6. 3 ±2. 1 ) cm and (5.6 ± 1.6) cm in ODG group, the difference was not significant. The number of lymph node dissections was also similar: (33 ± 13) in LADG group and (33 ± 16) in ODG group. The incidence of postoperative complications in LADG group was significantly lower than that in ODG group ( 6. 7% vs.13. 1%, P < 0. 05). During the follow-up period of 6-72 months (average 37 months), the 1-, 3-and 5-year survival rates were, respectively, 87. 2%, 57. 2% and 50. 3% in LADG group and 87. 1%, 54. 1%and 49. 2% in ODG group, the difference was not significant. The differences in recurrence and metastasis between the two groups were not statistically significant. Conclsion Laparoscopy-assisted gastrectomy for advanced gastric cancer is not significantly different with open surgery in postoperative survival rate or recurrence. It is less traumatic and of fewer complications.